ADR News Bulletin 2010 April (Volume 12 Number 1)
Healthcare professional
Industry member
Therapeutic Products
1 April 2010
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Association between UGT1A1 variant alleles and irinotecan-induced severe neutropenia
Increased myopathy with combination use of ER niacin/laropiprant (Tredaptive®) and simvastatin 40mg in Chinese patients
Sitagliptin- a new class of antidiabetic agents and acute pancreatitis
Illegal product- Huo Luo Jing Dan [活絡金丹] adulterated wtih undeclared medicinal ingredients
Analysis of adverse event reports for year 2009
Osteonecrosis of the jaw associated with bisphosphonates
Erythropoietin stimulating agents (ESAs): A safety update
An update on the National Immunisation Registry & H1N1 vaccination records
Cessation of the marketing of Mediaxal® in Singapore
Package insert amendments reflecting safety issues
Sibutramine and cardiovascular risk- an interim regulatory update
Click on the link below to download the issue in pdf:
